Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi

Amila Suraweera(Translational Research Institute), Derek J. Richard(Translational Research Institute)
Frontiers in Oncology
March 29, 2018
Cited by 655


Related Papers